Literature DB >> 7770606

Profile of action of 5-HT3 receptor antagonists, ondansetron and WAY 100289, in the elevated plus-maze test of anxiety of mice.

R J Rodgers1, J C Cole, J M Tredwell.   

Abstract

The effects of ondansetron (0.001-0.1 mg/kg) and the novel 5-HT3 receptor antagonist, WAY 100289 (0.01-10.0 mg/kg), on anxiety were examined in male mice using an ethological version of the elevated plus-maze paradigm. This procedure involves scoring specific aspects of defensive behaviour in addition to the more usual spatiotemporal measures. Results show that, at the doses tested, neither compound produced a behavioural profile consistent with anxiety reduction. Indeed, the lowest dose of ondansetron (0.001 mg/kg) produced some behavioural trends more typically associated with mild anxiety enhancement. Data are discussed in relation to the enigmatic effects of 5-HT3 receptor antagonists in animal models of anxiety. It is suggested that the large within- and between-test variability observed with these compounds may indicate an action on mechanisms other than anxiety.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7770606     DOI: 10.1007/bf02246105

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  38 in total

1.  Handling history of rats modifies behavioural effects of drugs in the elevated plus-maze test of anxiety.

Authors:  N Andrews; S E File
Journal:  Eur J Pharmacol       Date:  1993-04-22       Impact factor: 4.432

Review 2.  A proposed new nomenclature for 5-HT receptors.

Authors:  P P Humphrey; P Hartig; D Hoyer
Journal:  Trends Pharmacol Sci       Date:  1993-06       Impact factor: 14.819

Review 3.  5-HT receptors as targets for the development of novel anxiolytic drugs: models, mechanisms and future directions.

Authors:  J E Barrett; K E Vanover
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

4.  The use of a plus-maze to measure anxiety in the mouse.

Authors:  R G Lister
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

5.  Ondansetron, gender and antipredator defensive behaviour.

Authors:  J K Shepherd; R J Rodgers; R J Blanchard; L K Magee; D C Blanchard
Journal:  J Psychopharmacol       Date:  1993-01       Impact factor: 4.153

6.  Highly potent inhibitory effects of 5-HT3 receptor antagonist, GR38032F, on non-opioid defeat analgesia in male mice.

Authors:  R J Rodgers; J K Shepherd; J I Randall
Journal:  Neuropharmacology       Date:  1990-01       Impact factor: 5.250

7.  Anxiolytic profile of GR 38032F in the potentiated startle paradigm.

Authors:  B. Glenn; S. Green
Journal:  Behav Pharmacol       Date:  1989       Impact factor: 2.293

8.  Comparison of acute and chronic treatment of various serotonergic agents with those of diazepam and idazoxan in the rat elevated X-maze.

Authors:  I K Wright; M Heaton; N Upton; C A Marsden
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

9.  Antianxiety and behavioral suppressant actions of the novel 5-HT1A receptor agonist, flesinoxan.

Authors:  R J Rodgers; J C Cole; A Davies
Journal:  Pharmacol Biochem Behav       Date:  1994-08       Impact factor: 3.533

10.  Ethological evaluation of the effects of acute and chronic buspirone treatment in the murine elevated plus-maze test: comparison with haloperidol.

Authors:  J C Cole; R J Rodgers
Journal:  Psychopharmacology (Berl)       Date:  1994-03       Impact factor: 4.530

View more
  4 in total

Review 1.  Modulation of ligand-gated ion channels by antidepressants and antipsychotics.

Authors:  Gerhard Rammes; Rainer Rupprecht
Journal:  Mol Neurobiol       Date:  2007-04       Impact factor: 5.590

Review 2.  Ondansetron. A review of its pharmacology and preliminary clinical findings in novel applications.

Authors:  M I Wilde; A Markham
Journal:  Drugs       Date:  1996-11       Impact factor: 9.546

3.  Improvements in hippocampal-dependent learning and decremental attention in 5-HT(3) receptor overexpressing mice.

Authors:  Amber V Harrell; Andrea M Allan
Journal:  Learn Mem       Date:  2003 Sep-Oct       Impact factor: 2.460

4.  Molecular basis of atypicality of bupropion inferred from its receptor engagement in nervous system tissues.

Authors:  Eric J Kim; Klara Felsovalyi; Lauren M Young; Sergey V Shmelkov; Michael F Grunebaum; Timothy Cardozo
Journal:  Psychopharmacology (Berl)       Date:  2018-07-01       Impact factor: 4.530

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.